Evidence & regulatory context
- Mechanism
- Device (phospholipid-coated oxygen microbubbles); not a ChEMBL entity
- Target
- Not recorded
- Injury models
- Other
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatOtherWistarMalen = 10 male Wistar rats, 5 per group; one control excluded for…Intraperitoneal perfusion through a 12-gauge indwelling catheter, warmed to 40.4 degrees CTotal infused volume 107 +/- 9 mL of 70 vol% oxygen microfo…Bolus started immediately before pleural perforation and continued thereafter
Model: Right pneumothorax by scalpel perforation of the pleura, producing acute lung trauma with refractory hypoxaemia
Peritoneal oxygen microbubble perfusion gave 100% survival to the 2 hour endpoint, versus median survival of 18.5 minutes for oxygenated saline and 15.5 minutes for untreated controls (log-rank P = 0.002). Oxygen saturation and heart rate stayed within normal ranges for 2 hours in treated rats. Int…
Extraction: extract · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.